Literature DB >> 25097730

Repeat dosing of rocuronium-sugammadex: unpredictable.

Yoon-Hee Kim1.   

Abstract

Entities:  

Year:  2014        PMID： 25097730      PMCID： PMC4121487          DOI： 10.4097/kjae.2014.67.1.1

Source DB:  PubMed          Journal:  Korean J Anesthesiol        ISSN： 2005-6419


× No keyword cloud information.
  18 in total

1.  A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host.

Authors:  Anton Bom; Mark Bradley; Ken Cameron; John K Clark; Jan Van Egmond; Helen Feilden; Elizabeth J MacLean; Alan W Muir; Ronald Palin; David C Rees; Ming-Qiang Zhang
Journal:  Angew Chem Int Ed Engl       Date:  2002-01-18       Impact factor: 15.336

2.  Sugammadex: a revolutionary approach to neuromuscular antagonism.

Authors:  Aaron F Kopman
Journal:  Anesthesiology       Date:  2006-04       Impact factor: 7.892

3.  Sugammadex: an opportunity to change the practice of anesthesiology?

Authors:  Ronald D Miller
Journal:  Anesth Analg       Date:  2007-03       Impact factor: 5.108

4.  Non-steroidal neuromuscular blocking agents to re-establish paralysis after reversal of rocuronium-induced neuromuscular block with sugammadex.

Authors:  Hans D de Boer; Jacques J Driessen; Jan van Egmond; Leo H D J Booij
Journal:  Can J Anaesth       Date:  2008-02       Impact factor: 5.063

5.  Anesthetic practice in Japan: past, present, and future.

Authors:  Michiaki Yamakage; Akiyoshi Namiki
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

6.  Preclinical pharmacology of sugammadex.

Authors:  Anton Bom; Frank Hope; Samantha Rutherford; Karen Thomson
Journal:  J Crit Care       Date:  2009-03       Impact factor: 3.425

7.  First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide.

Authors:  Francois Gijsenbergh; Steven Ramael; Natalie Houwing; Thijs van Iersel
Journal:  Anesthesiology       Date:  2005-10       Impact factor: 7.892

8.  Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.

Authors:  H D de Boer; J van Egmond; F van de Pol; A Bom; L H D J Booij
Journal:  Br J Anaesth       Date:  2006-02-07       Impact factor: 9.166

Review 9.  Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.

Authors:  Stefan Josef Schaller; Heidrun Fink
Journal:  Core Evid       Date:  2013-09-25

10.  The use of 3 sugammadex out of 5 reversal of during recovery of rocuronium-induced neuromuscular blockade in a patient with post-tonsillectomy hemorrhage: a case report.

Authors:  Hee-Jong Lee; Kyo Sang Kim; Tae Yeon Kim; Jeoung Hyuk Lee; Miae Jeong
Journal:  Korean J Anesthesiol       Date:  2014-07-29
View more
  1 in total

1.  Sugammadex: Efficacy and Practicality in the Dental Office.

Authors:  Stephen Goetz; Benjamin Pritts; Bryant Cornelius
Journal:  Anesth Prog       Date:  2018
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.